Source: PLOS ONE. Unidade: FMRP
Subjects: LEUCEMIA, CITOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FIGUEIREDO-PONTES, Lorena L. de et al. Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway. PLOS ONE, v. 6, n. 10, p. e26713-1 - e26713-11, 2011Tradução . . Disponível em: https://doi.org/10.1371/journal.pone.0026713. Acesso em: 17 maio 2024.APA
Figueiredo-Pontes, L. L. de, Assis, P. A., Santana-Lemos, B. A. A., Jácomo, R. H., Lima, A. S. G., Garcia, A. B., et al. (2011). Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway. PLOS ONE, 6( 10), e26713-1 - e26713-11. doi:10.1371/journal.pone.0026713NLM
Figueiredo-Pontes LL de, Assis PA, Santana-Lemos BAA, Jácomo RH, Lima ASG, Garcia AB, Thomé CH, Araújo AG de, Panepucci RA, Zago MA, Nagler A, Falcao RP, Rego EM. Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway [Internet]. PLOS ONE. 2011 ; 6( 10): e26713-1 - e26713-11.[citado 2024 maio 17 ] Available from: https://doi.org/10.1371/journal.pone.0026713Vancouver
Figueiredo-Pontes LL de, Assis PA, Santana-Lemos BAA, Jácomo RH, Lima ASG, Garcia AB, Thomé CH, Araújo AG de, Panepucci RA, Zago MA, Nagler A, Falcao RP, Rego EM. Halofuginone has anti-proliferative effects in acute promyelocytic leukemia by modulating the transforming growth factor beta signaling pathway [Internet]. PLOS ONE. 2011 ; 6( 10): e26713-1 - e26713-11.[citado 2024 maio 17 ] Available from: https://doi.org/10.1371/journal.pone.0026713